Variants in ADRB1 and CYP2C9: Association with Response to Atenolol and Losartan in Marfan Syndrome
Sara L. Van Driest, Lynn A. Sleeper, Bruce D. Gelb, Shaine A. Morris, Harry C. Dietz, Geoffrey A. Forbus, Elizabeth Goldmuntz, Arvind Hoskoppal, J. Howard James, Teresa M. Lee, Jami C. Levine, Jennifer S. Li, Bart Loeys, Larry W. Markham, Josephina Meester, Seema Mital, Jonathan D. Mosley, Aaron Olson, Marjolijn Renard, Christian M. Shaffer, Angela M. Sharkey, Luciana Young, Ronald V. Lacro, Dan M. Roden
Topics & Concepts
AtenololMedicineLosartanMarfan syndromeInternal medicineCYP2C9PlaceboRandomized controlled trialGenotypeCardiologyBlood pressureAngiotensin IIGeneticsBiologyCytochrome P450Alternative medicineMetabolismGenePathologyConnective tissue disorders researchCongenital heart defects researchTendon Structure and Treatment